Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806.

Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806. Breast Cancer Res Treat. 2006 Dec; 100(3):301-8.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents, Phytogenic
Breast Neoplasms
Female
Humans
Interleukin-6
Kaplan-Meier Estimate
Middle Aged
Neoplasm Metastasis
Paclitaxel
Prognosis
Time Factors
Treatment Outcome

authors with profiles

Gini Fleming